- Stock Code: 301393
Stock Abbreviation: Haofan Biotechnology
Announcement Number: 2026-020
Suzhou Haofan Biotechnology Co., Ltd. announces the pre-disclosure of the Employee Strategic Placement Asset Management Plan's share reduction. The shareholder, Minsheng Securities - CITIC Bank - Minsheng Securities Haofan Biotechnology Strategic Placement No. 1 Collective Asset Management Plan (hereinafter referred to as the "Employee Strategic Placement Asset Management Plan"), holds 541,817 shares of Suzhou Haofan Biotechnology Co., Ltd. (hereinafter referred to as the "Company" or "Haofan Biotechnology"). The plan intends to reduce its holdings by no more than 541,817 shares (accounting for 0.50% of the company's total share capital) within three months after 15 trading days from the date of this announcement through centralized bidding or block trading. The company has recently received a notification letter from the manager of the Employee Strategic Placement Asset Management Plan. Given that some directors and senior management of the company participate in the Employee Strategic Placement Asset Management Plan, the following information is disclosed in accordance with the "Shenzhen Stock Exchange Growth Enterprise Market Listing Rules" and other relevant regulations:
1. Shareholder and Holding Basic Information
The shareholder intending to reduce its holdings is the Employee Strategic Placement Asset Management Plan. As of the date of this announcement, the plan holds 541,817 shares of the company (accounting for 0.50% of the company's total share capital), with shares sourced from the initial public offering of strategic placement for executives and employees.